Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cyanocobalamin + collagen is a combination product primarily utilized in the dietary supplement and nutricosmetic sectors to support skin health, joint function, and metabolic processes. Cyanocobalamin, a synthetic form of Vitamin B12, is essential for DNA synthesis, red blood cell formation, and neurological health, acting as a cofactor for methionine synthase and methylmalonyl-CoA mutase. Collagen, a fibrous structural protein, provides the scaffold for the extracellular matrix in skin, bone, and cartilage. When ingested or applied topically, collagen peptides may promote the synthesis of endogenous collagen and improve tissue elasticity. This combination is frequently marketed for its potential anti-aging benefits and its role in maintaining the integrity of connective tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyanocobalamin + collagen.